KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 133 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $196,000 | -28.2% | 57,626 | -13.7% | 0.00% | -50.0% |
Q1 2018 | $273,000 | +143.8% | 66,812 | +176.7% | 0.00% | +100.0% |
Q4 2017 | $112,000 | -46.2% | 24,148 | -17.6% | 0.00% | -50.0% |
Q3 2017 | $208,000 | -24.9% | 29,300 | -23.5% | 0.00% | -20.0% |
Q2 2017 | $277,000 | +20.4% | 38,311 | +2.8% | 0.01% | -16.7% |
Q1 2017 | $230,000 | -25.6% | 37,275 | -29.3% | 0.01% | -53.8% |
Q4 2016 | $309,000 | +15.7% | 52,738 | +30.5% | 0.01% | -23.5% |
Q2 2016 | $267,000 | -8.2% | 40,400 | -35.2% | 0.02% | -26.1% |
Q1 2016 | $291,000 | -28.1% | 62,300 | -22.3% | 0.02% | -47.7% |
Q4 2015 | $405,000 | – | 80,151 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 1,605,800 | $16,026,000 | 4.65% |
Baupost Group | 25,791,678 | $257,401,000 | 4.29% |
1492 Capital Management LLC | 264,297 | $2,638,000 | 1.67% |
Cormorant Asset Management, LP | 826,000 | $8,243,000 | 1.10% |
FALCON POINT CAPITAL, LLC | 251,137 | $2,506,000 | 0.85% |
OAK RIDGE INVESTMENTS LLC | 3,291,711 | $32,851,000 | 0.70% |
Knoll Capital Management, LLC | 200,000 | $1,996,000 | 0.64% |
Rhenman & Partners Asset Management AB | 534,000 | $5,329,000 | 0.64% |
Old West Investment Management, LLC | 79,667 | $795,000 | 0.55% |
THREE BAYS CAPITAL LP | 1,284,000 | $12,814,000 | 0.53% |